Načítá se...

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

Dementia due to Alzheimer’s disease (AD) is estimated to reach epidemic proportions by the year 2030. Given the limited accuracy of current AD clinical diagnosis, biomarkers of AD pathologies are currently being sought. Reductions in cerebrospinal fluid levels of β-amyloid 42 (a marker of amyloid pl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fagan, Anne M, Perrin, Richard J
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477809/
https://ncbi.nlm.nih.gov/pubmed/22917147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm.12.42
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!